Atopia Therapeutics
Christine Serratrice is the Co-Founder and Chief Medical Officer at Atopia Therapeutics (formerly HpVac). Christine also holds the position of CMO at Dorphan SA and Chief Medical Officer at Geneva Biotech Center (GBC) SA. With a background in internal medicine, Christine has previously served as an Assistant Head at Fondation Hopital Saint Joseph and Chief resident at APHM. Christine holds a Doctorat en medecine from Faculté de Medecine Marseille and a Diploma of Advanced Studies in Management of clinical trials from the University of Geneva.
This person is not in any teams
Atopia Therapeutics
Atopia Therapeutics is focused on the development of a preventive and therapeutic first-line therapy against asthma, eczema, food allergies and related allergic diseases.